跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTAIR 100 IR & 300 IR COMPRIMIDOS SUBLINGUALES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ACTAIR 100 IR & 300 IR COMPRIMIDOS SUBLINGUALES
Approved
STANDARD
ACTAIR 100 IR & 300 IR COMPRIMIDOS SUBLINGUALES
Stallergenes
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 18, 2021
Approval ID
5852cf05b052129d
Company
Stallergenes
Type
Standard
Approval Details
Approval Id
5852cf05b052129d
Drug Cima Aemps Name
ACTAIR 100 IR & 300 IR COMPRIMIDOS SUBLINGUALES
Register Number
86402
Holder Company Name
Stallergenes
Marketing Company Name
Stallergenes Iberica S.A.
Holder Company Detail Path
/organization/stallergenes
Authorization Date
2021-11-18
Dosage Form
COMPRIMIDO SUBLINGUAL
Dose
100 IR + 300 IR
Route Of Administration
VÍA SUBLINGUAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Stallergenes
Company Detail Path
/organization/stallergenes
Company Information
Pharmaceutical Company Name
STALLERGENES
Country Name
France
City Name
antony,ile de france,country_fr
Address
6 RUE ALEXIS DE TOCQUEVILLE
Active Ingredients
EXTRACTO ALERGENICO DE DERMATOPHAGOIDES FARINAE
150 IR
EXTRACTO ALERGENICO DE DERMATOPHAGOIDES PTERONYSSINUS
150 IR
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 18, 2021
Approval ID
5852cf05b052129d
Type
Standard
Back to CIMA-AEMPS Approvals
